Xiujuan Wu

P.R. China
Chongqing, 400038, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Novel therapeutic strategies for targeting fatty acid oxidation in cancer.

Novel therapeutic strategies for targeting fatty acid oxidation in cancer.

Journal: Biomarker research
Published: May 29, 2025

Comparative study of surgical outcomes and quality of life between endoscopic and robotic thyroidectomy for differentiated thyroid cancer patients.

Comparative study of surgical outcomes and quality of life between endoscopic and robotic thyroidectomy for differentiated thyroid cancer patients.

Journal: International journal of surgery (London, England)
Published: March 18, 2025

Patient-reported outcomes by individuals with differentiated thyroid cancer who underwent minimal-access versus conventional open thyroidectomy: a real-world propensity score-matching study.

Patient-reported outcomes by individuals with differentiated thyroid cancer who underwent minimal-access versus conventional open thyroidectomy: a real-world propensity score-matching study.

Journal: International journal of surgery (London, England)
Published: December 20, 2024

CD36 Inhibits Triple-Negative Breast Cancer Progression by Transcriptionally Upregulating Caveolin-1 and Promoting Lipid-Reactive Oxygen Species-Related Ferroptosis.

CD36 Inhibits Triple-Negative Breast Cancer Progression by Transcriptionally Upregulating Caveolin-1 and Promoting Lipid-Reactive Oxygen Species-Related Ferroptosis.

Journal: MedComm
Published: November 14, 2024

Tumor-Derived Extracellular Vesicles Enable Tumor Tropism Chemo-Genetherapy for Local Immune Activation in Triple-Negative Breast Cancer.

Tumor-Derived Extracellular Vesicles Enable Tumor Tropism Chemo-Genetherapy for Local Immune Activation in Triple-Negative Breast Cancer.

Journal: ACS nano
Published: October 30, 2024

Landscape of metabolic alterations and treatment strategies in breast cancer.

Landscape of metabolic alterations and treatment strategies in breast cancer.

Journal: Genes & diseases
Published: March 13, 2024

Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study.

Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study.

Journal: BMC medicine
Published: October 17, 2023

Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority.

Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority.

Journal: Frontiers in immunology
Published: July 20, 2023

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.

Journal: The oncologist
Published: May 31, 2023

A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.

A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.

Journal: MedComm
Published: April 10, 2023

Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery.

Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery.

Journal: JAMA surgery
Published: October 05, 2022

Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis.

Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis.

Journal: Therapeutic advances in medical oncology
Published: July 23, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026